US6258583B1

US6258583B1 - Type II restriction endonuclease, Hpy188I, obtainable from helicobacter pylori J188 and a process for producing the same

Info

Publication number: US6258583B1
Application number: US09/393,245
Authority: US
Inventors: Richard D. Morgan; Qing Xu
Original assignee: New England Biolabs Inc; Vanderbilt University
Current assignee: New England Biolabs Inc; Vanderbilt University
Priority date: 1999-09-10
Filing date: 1999-09-10
Publication date: 2001-07-10
Anticipated expiration: 2019-09-10
Also published as: WO2001018186A1

Abstract

In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J188 (NEB#1174), hereinafter referred to as "Hpy188I", which endonuclease:(1) recognizes the nucleotide sequence 5'-TCNGA-3' in a double-stranded DNA molecule as shown below,(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);(2) cleaves said sequence in the phosphodiester bonds between the N and G as indicated with the arrows; and(3) cleaves double-stranded PhiX174 DNA to produce 18 fragments, including fragments of 1331, 813, 572, 525, 396, 302, 293, 219 base pairs, and 10 fragments smaller than 200 base pairs.

Description

BACKGROUND OF THE INVENTION

The present invention relates to a new Type II restriction endonuclease, Hpy188I, obtainable from Helicobacter pylori J188, and to the process for producing the same.

Restriction endonucleases are a class of enzymes that occur naturally in bacteria. When they are purified away from other contaminating bacterial components, restriction endonucleases can be used in the laboratory to break DNA molecules into precise fragments. This property enables DNA molecules to be uniquely identified and to be fractionated into their constituent genes. Restriction endonucleases have proved to be indispensable tools in modern genetic research. They are the biochemical ‘scissors’ by means of which genetic engineering and analysis is performed.

Restriction endonucleases act by recognizing and binding to particular sequences of nucleotides (the ‘recognition sequence’) along the DNA molecule. Once bound, they cleave the molecule within, or to one side of, the sequence. Different restriction endonucleases have affinity for different recognition sequences. The majority of restriction endonucleases recognize sequences of 4 to 6 nucleotides in length, although recently a small number of restriction endonucleases which recognize 7 or 8 uniquely specified nucleotides have been isolated. Most recognition sequences contain a dyad axis of symmetry and in most cases all the nucleotides are uniquely specified. However, some restriction endonucleases have degenerate or relaxed specificities in that they recognize multiple bases at one or more positions in their recognition sequence, and some restriction endonucleases recognize asymmetric sequences. HaeIII, which recognizes the sequence 5′-GGCC-3′, is an example of a restriction endonuclease having a symmetrical, non-degenerate recognition sequence, while HaeII, which recognizes 5′-(Pu)GCGC(Py)-3′ typifies restriction endonucleases having a degenerate or relaxed recognition sequence. Endonucleases with symmetrical recognition sequences generally cleave symmetrically within or adjacent to the recognition site, while those that recognize assymmetric sequences tend to cleave at a distance of from 1 to 18 nucleotides away from the recognition site. More than two hundred unique restriction endonucleases have been identified among several thousands of bacterial species that have been examined to date.

Endonucleases are named according to the bacteria from which they are derived. Thus, the species Haemophilus aegyptius, for example synthesizes 3 different restriction endonucleases, named HaeI, HaeII and HaeIII. These enzymes recognize and cleave the sequences 5′-(AT)GGCC(AT)-3′, 5′-(Pu)GCGC(Py)-3′ and 5′-GGCC-3′ respectively. Escherichia coli RY13, on the other hand, synthesizes only one enzyme, EcoRI, which recognizes the sequence 5′-GAATTC-3′.

While not wishing to be bound by theory, it is thought that in nature, restriction endonucleases play a protective role in the welfare of the bacterial cell. They enable bacteria to resist infection by foreign DNA molecules like viruses and plasmids that would otherwise destroy or parasitize them. They impart resistance by binding to infecting DNA molecule and cleaving them in each place that the recognition sequence occurs. The disintegration that results inactivates many of the infecting genes and renders the DNA susceptible to further degradation by exonucleases.

A second component of restriction systems are the modification methylases. These enzymes are complementary to restriction endonucleases and they provide the means by which bacteria are able to protect their own DNA and distinguish it from foreign, infecting DNA. Modification methylases recognize and bind to the same nucleotide recognition sequence as the corresponding restriction endonuclease, but instead of breaking the DNA, they chemically modify one or other of the nucleotides within the sequence by the addition of a methyl group. Following methylation, the recognition sequence is no longer bound or cleaved by the restriction endonuclease. The DNA of a bacterial cell is always modified, by virtue of the activity of its modification methylase and it is therefore insensitive to the presence of the endogenous restriction endonuclease. It is only unmodified, and therefore identifiably foreign, DNA that is sensitive to restriction endonuclease recognition and attack. More than 3000 restriction endonucleases have been isolated from various bacterial strains. Of these, more than 200 recognize unique sequences, while the rest share common recognition specificities. Restriction endonucleases which recognize the same nucleotide sequence are termed “isoschizomers.” Although the recognition sequences of isoschizomers are the same, they may vary with respect to site of cleavage (e.g., XmaI v. SmaI, Endow, et al., J. Mol. Biol. 112:521 (1977); Waalwijk, et al., Nucleic Acids Res. 5:3231 (1978)) and in cleavage rate at various sites (XhoI v. PaeR7I, Gingeras, et al., Proc. Natl. Acad. Sci. U.S.A. 80:402 (1983)).

There is a continuing need for novel type II restriction endonucleases. Although type II restriction endonucleases which recognize a number of specific nucleotide sequences are currently available, new restriction endonucleases which recognize novel sequences provide greater opportunities and ability for genetic manipulation. Each new unique endonuclease enables scientists to precisely cleave DNA at new positions within the DNA molecule, with all the opportunities this offers.

SUMMARY OF THE INVENTION

In accordance with the present invention, there is provided a novel restriction endonuclease obtainable from Helicobacter pylori J188 (NEB#1174), hereinafter referred to as “Hpy188I”, which endonuclease:

(1) recognizes the nucleotide sequence 5′-TCNGA-3′ in a double-stranded DNA molecule as shown below,

5′-TCN↓GA-3′

3′-AG↑NCT-5′

(wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T);

(2) cleaves said sequence in the phosphodiester bonds between the N and G as indicated with the arrows; and

(3) cleaves double-stranded PhiX174 DNA to produce 18 fragments, including fragments of 1331, 813, 572, 525, 396, 302, 293, 219 base pairs, and 10 fragments smaller than 200 base pairs.

The present invention further relates to a process for the production of the novel restriction endonuclease Hpy188I. This process comprises either culturing Helicobacter pylori J188 under conditions suitable for expressing Hpy188I, collecting the cultured cells, obtaining a cell-free extract therefrom and separating and collecting the restriction endonuclease Hpy188I from the cell-free extract, or culturing a transformed host, such as E. coli, containing the genes for the Hpy188I methylase and endonuclease, collecting the cultured cells, obtaining a cell-free extract therefrom and separating and collecting the restriction endonuclease Hpy188I from the cell-free extract.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1—Agarose gel showing Hpy188I cleavage of various DNAs.

FIG. 2—Determination of the Hpy188I cleavage site.

FIG. 3—Map and DNA sequence of the Hpy188I gene locus (SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4).

DETAILED DESCRIPTION OF THE INVENTION

The recognition sequence of the endonuclease of the present invention may be determined by mapping the locations of several Hpy188I cleavage sites in various DNAs and comparing the DNA sequences of these regions for homology, then comparing the predicted cleavage fragments of the putative recognition sequence with the observed restriction fragments produced by Hpy188I cleavage of various DNAs. The endonuclease Hpy188I was found to cleave PhiX174 DNA more than ten times, producing fragments of approximately 1350, 800, 575, 525, 400, 300 and 225 bp along with a number of smaller fragments. The location of several cut sites were mapped to approximate positions of 1075 and 2400 (the 1350 bp fragment) and 4225 and 5025 (the 800 bp fragment) by simultaneously digesting PhiX174 DNA with Hpy188I and with endonucleases which cleave at known positions, such as SspI, BsrBI, NciI, SacII, StuI and PstI (FIG. 1). The approximate size of several of the larger DNA fragments produced by Hpy188I digestion of PhiX174 DNA were entered into the program SITES (Gingeras, et al., Nucl. Acids Res. 5:4105 (1978)), which generates potential recognition sequences for the input data by comparing the fragment sizes which would result from cleavage of the DNA at any given recognition pattern with the input fragment sizes. One such potential pattern generated was TCNGA, which occurs in PhiX174 DNA at positions consistant with the mapping data obtained, i.e. at positions 1071 and 2402, and 4223 and 5036, as well as 14 other sites. The size of fragments predicted from cleavage at TCNGA sites in PhiX174, pBR322, pUC19, T7 and lambda DNAs matched the observed size of fragments from cleavage of these DNAs with Hpy188I, from which we conclude that Hpy188I recognizes the sequence 5′-TCNGA-3′.

The point of cleavage within the Hpy188I recognition sequence may be determined through dideoxy sequencing analysis of the terminal base sequence obtained from Hpy188I cleavage of a suitable DNA substrate (Sanger, et al., PNAS 74:5463-5467 (1977) Brown, et al., J. Mol. Biol. 140:143-148 (1980)). By the above referenced method (FIG. 2, exemplified in Example II) is was found that Hpy188I cleaves the phosphodiester bond between the unspecified nucleotide N and the G in the recognition sequence 5′-TCN/GA-3′ to produce a 1 base 3′ extension, as indicated by the arrows:

5′-TCN↓GA-3′

3′-AG↑NCT-5′

The enzyme of the present invention also has the following properties:

(a) Obtimal buffer composition: Of the four standard NEBuffers tested, the optimal endonuclease reaction buffer was NEBuffer IV. Relative activity in NEBuffer I was approximately 90%, NEBuffer II was 50%, while relative activity in NEBuffer III was approximately 10%.

In accordance with the present invention, Hpy188I is obtained by culturing Helicobacter pylori J188 and recovering the endonuclease from the cells. A sample of Helicobacter pylori J188 has been deposited under the terms and conditions of the Budapest Treaty with the American Type Culture Collection (ATCC) on Jan. 3, 2001, and received ATCC Patent Accession No. PTA-2878.

In accordance with the present invention, isoschizomers of Hpy188 have been identified, which are substantially similar to Hpy188I (having greater than about 90% homology at the amino acid level), in other Helicobacter strains, such as Helicobacter pylori J166. Of nine different Helicobacter strains studied, two of which the DNA sequence is known, it was observed that the genes for various given restriction endonucleases and methylases are present and functional in a number, though not all, of these strains. The presence of Hpy188I or isoschizomers thereof, can be readily assertained in various Helicobacter strains by any of several methods. The genomic DNA of the strain may be prepared (as outlined in the example below) and digested with the enzyme of the current application. If Hpy188I cleaves the genomic DNA, that strain does not contain an active Hpy188I methyl-transferase, whereas if the DNA is not cleaved, it is likely the Hpy188I methyl-transferase is present in that strain, and thus potentially the Hpy188I endonuclease as well. The Hpy188I genes may also be obtained form various Helicobacter strains by PCR amplification, using the sequence of the Hpy188I endonuclease and methylase genes (SEQ ID NO:1 AND SEQ ID NO:3) provided in this application as the guide to PCR primer design. Helicobacter strains containing the enzymes of the present invention may also be identified by the methods exemplified in Schildkraut, Genetic Engineering, Volume 6, 117-139, J. K. Setlow and A. Hollaender, eds. (1984), which methods comprise growing cells, obtaining a cell-free extract of proteins from the cells and assaying that extract for the presence of Hpy188I endonuclease activity.

For recovering the enzyme of the present invention Helicobacter pylori J188 may be grown using any suitable technique. For example, Helicobacter pylori J188 may be grown in Brucella broth media (BBL Microbiology Systems, Cockeysville, Md.) incubated at 37° C. Cells in the late logarithmic stage of growth are collected by centrifugation and either disrupted immediately or stored frozen at −70° C.

The Hpy188I enzyme can be isolated from Helicobacter pylori J188 cells by conventional protein purification techniques. For example, cell paste is suspended in a buffer solution and treated by sonication, high pressure dispersion or enzymatic digestion to allow extraction of the endonuclease by the buffer solution. Intact cells and cellular debris are then removed by centrifugation to produce a cell-free extract containing Hpy188I. The Hpy188I endonuclease is then purified from the cell-free extract by ion-exchange chromatography, affinity chromatography, molecular sieve chromotography, or a combination of these methods to produce the endonuclease of the present invention.

The endonuclease of the present invention along with its corresponding methylase may also be obtained using recombinant DNA techniques, such as the methylation selection technique disclosed by Wilson, et al., U.S. Pat. No. 5,200,333. As an example, DNA from a bacterial strain which contains an R-M system, such as Helicobacter pylori, is purified, partially digested with suitable type II endonucleases, and ligated to an appropriate cleaved, dephosphorylated cloning vector. The ligated DNA is transformed into an appropriate host, such as E. coli, the transformants are pooled and the population of cloning vectors are purified to form libraries. The library of clones is then challenged by digesting with an endonuclease which will selectively destroy vectors which do not contain and express the methylase of the R-M system being cloned. Vectors which contain and express the methylase gene of interest will be modified at the endonuclease recognition sites of the challenging endonuclease and thus be immune from cleavage. The challenged clone pools are then transformed back into the appropriate host to recover the undigested, presumably methylase expressing clones. The transformants may be screened for endonuclease activity or cycled through further rounds of purification and selection. Finally, individual transformants are selected and their DNA purified. These clones are analyzed for resistance to cleavage by the endonuclease of interest and for common insert DNA. Cell extracts prepared from transformants which demonstrate endonuclease resistance are assayed in vitro for methyltransferase and endonuclease activities.

The present invention is further illustrated by the following Examples. These Examples are provided to aid in the understanding of the invention and are not construed as a limitation thereof.

The references cited above and below are herein incorporated by reference.

EXAMPLE I Production of Hpy188I Endonuclease

Helicobacter pylori J188 strain NEB#1174 was grown in Brucella broth media. The cells were incubated anaerobically under 5% CO₂at 37° C. until late logarithmic stage. The cells were then harvested by centrifugation and stored frozen at −70° C.

10 grams of the cells obtained above were suspended in 40 mls buffer A (20 mM Tris-HCl, 0.1 mM EDTA, 1 mM dithiothreitol, 5% glycerol, pH 7.6 at 25° C.) adjusted to 50 mM NaCl. The cell suspension was sonicated until approximately 50 mg protein per gram of cells was released. The lysate was centrifuged at 15,000 rpm for 20 minutes at 4° C. in a Beckman JA17 rotor. 42 ml of supernatant was obtained containing approximately 50,000 units of Hpy188I and 500 mg of soluble protein.

The supernatant solution was applied to a 20 ml Heparin Hyper-D column (Biosepra, Marlborough, Mass.) equilibrated in buffer A adjusted to 50 mM NaCl. A 40 ml wash of buffer A adjusted to 50 mM NaCl was applied, then a 200 ml linear gradient of NaCl from 50 mM to 1M in buffer A was applied and fractions of 4 ml were collected. Fractions were assayed for Hpy188I endonuclease activity by incubation with 1 μg Lambda DNA (NEB) in 50 μl NEBuffer 4 for one hour at 37° C. Hpy188I activity eluted at 0.3M to 0.38M NaCl.

The Heparin Hyper-D column fractions containing the Hpy188I activity were pooled, diluted to 50 mM NaCl in buffer A and applied to a 1 ml Mono-S column (Pharmacia, Piscataway, N.J.) equilibrated in buffer A adjusted to 50 mM NaCl. The column was washed with 2 mls buffer A adjusted to 50 mM NaCl. The protein solution was eluted with a 50 ml gradient of 50 mM to 1M NaCl in buffer A and fractions were tested for Hpy188I activity. The Hpy188I activity eluted between 0.26M and 0.3M NaCl. The Hpy188I activity was pooled, diluted to 50 mM NaCl, and applied to a PolyCatA column (Custom LC Inc., Houston, Tex.) equilibrated in buffer A adjusted to 50 mM NaCl. The column was washed with buffer A adjusted to 50 mM NaCl and the Hpy188I enzyme was eluted with a 50 ml gradient of 50 mm to 0.6 M NaCl in buffer A. The Hpy188I activity eluted between 0.3 M and 0.38 M NaCl. The PolyCatA pool of Hpy188I was diluted to 0.1 M NaCl, passed through a 1 ml Mono-Q column (Pharmacia) onto a 3 ml Heparin-TSK column (Toso-Haas, Philadelphia, Pa.). The Mono-Q column was then removed from the FPLC apparatus and a 50 ml linear gradient from 0.1 M to 0.6 M NaCl in buffer A was applied to the Heparin-TSK column. The Hpy188I activity eluted between 0.38 M to 0.42 M NaCl and contained approximately 14,000 units of endonuclease activity. The Hpy188I obtained was substantially pure and free of contaminating endonuclease and exonuclease activities. A portion of this endonuclease was used to obtain N-terminal amino acid sequence information. To the remainder was added bovine serum albumin as a stabilizer to a final concentration of 200 μg/ml and the Hpy188I enzyme was dialyzed against storage buffer (50% glycerol, 50 mM NaCl, 20 mM Tris-HCl, 0.1 mM dithiothreitol, pH 7.5).

Activity Determination

Hpy188I activity: Samples of from 1 to 10 μls were added to 50 μls of substrate solution consisting of 1×NEBuffer 4 containing 1 μg Lambda phage DNA. The reaction was incubated at 37° C. for 5 to 60 mins. The reaction was terminated by adding 5 μls of a stop solution (50% glycerol, 50 mM EDTA pH 8.0, and 0.02% Bromophenol Blue). The reaction mixture was applied to a 1% agarose gel and electrophoresed. The bands obtained were identified in comparison with DNA size standards.

Unit Definition: One unit of Hpy188I is defined as the amount of Hpy188I required to completely cleave 1.0 μg of Lambda DNA in a total reaction volume of 50 μl NEBuffer 4, supplemented with 100 μg/ml bovine serum albumin, within one hour at 37° C.

Optimal Buffer Conditions: For optimum Hpy188I activity NEBuffer 4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 mM dithiothreitol (pH 7.9 at 25° C.), supplemented with 100 ug/ml bovine serum albumin, was used.

EXAMPLE II Determination of the Hpy188I Cleavage Site

The location of Hpy188I cleavage relative to the recognition sequence was determined by cleavage of a primer extension product, which was then electrophoresed alongside a set of standard dideoxy sequencing reactions produced from the same primer and template. M13mp18 DNA was employed as the template utilizing an Hpy188I recognition site at position 1353, conveniently located 54 bp 3′ of a priming site for a primer designated M13 Q1-Q2 (5′-dGGTCGCTGAGGCTTGCAGGG-3′ (SEQ ID NO:5)) and 53 bp 3′ of a priming site on the opposite strand for a primer designated M13 Q2-2 (5′-dCGTTTAATGGAAACTTCCTC-3′ (SEQ ID NO:7)).

Sequencing Reactions

The sequencing reactions were performed using the Sequenase version 2.0 DNA sequencing kit (Amersham Life Science) with modifications for the cleavage site determination. The template and primer (for the M13 Q1-Q2 primer) were assembled in a 0.5 mL eppendorf tube by combining 10 μl dH20, 4 μl 5×sequencing buffer (200 mM Tris pH 7.5, 250 mM NaCl, 100 mM MgCl2), 4 μl M13mp18 single stranded DNA (2 μg) and 2 μl of primer (M13 Q1-Q2 at 3.2 μM concentration). The template and primer (for the M13 Q2-2 primer) were assembled in a 0.5 mL eppendorf tube by combining 10 μl dH20, 4 μl 5×sequencing buffer (200 mM Tris pH 7.5, 250 mM NaCl, 100 mM MgCl2), 4 μl M13mp18 double stranded DNA (2 μg) and 2 μl of primer (M13 Q2-2 at 3.2 μM concentration). The primer-template solutions were incubated at 65° C. for 2 minutes, then cooled to 37° C. over 20 minutes in a beaker of 65° C. water on the benchtop to anneal the primer. The labeling mix and sequenase were diluted according to manufacturer's instructions. The annealed primer and template tube was placed on ice. To this tube were added 2 μl 100 mM DTT, 4 μl diluted dGTP labeling mix, 1 μl [α-³³P] dATP (2000 Ci/mmole, 10 mCi/ml) and 4 μl diluted T7 Sequenase polymerase. The reaction was mixed and incubated at room temperature for 5 minutes. 3.5 μl of this reaction was then transferred into each of four tubes containing 2.5 μl termination mix for the A, C, G and T sequencing termination reactions. To the remaining reaction was added to 17 μl of Sequence Extending Mix, which is a mixture of dNTPs (no ddNTPs) to allow extension of the primer through and well beyond the Hpy188I site with no terminations to create a labeled strand of DNA extending through the Hpy188I recognition site for subsequent cleavage. The reactions were incubated 5 minutes at 37° C. To the A, C, G and T reactions were added 4 μl of stop solution and the samples were stored on ice. The extension reaction was then incubated at 70° C. for 20 minutes to inactivate the DNA polymerase (Sequenase), then cooled on ice. 10 μl of the extension reaction was then placed in a 0.5 ml eppendorf tube. To this tube was added 1 μl (approximately 1 unit) Hpy188I endonuclease. This enzyme digest reaction was mixed and then incubated at 37° C. for 30 minutes, following which 6 μl of stop solution was added and mixed. The sequencing reaction products were electrophoresed on an 6% Bis-Acrylamide sequencing gel, with the Hpy188I digestions of the extension reaction next to the set of sequencing reactions produced from the same primer and template combination.

Results

Digestion of the extension reaction product from primer M13 Q1-Q2 with Hpy188I endonuclease produced a band which co-migrated with the unspecified nucleotide of the Hpy188I recognition sequence 5′-TCNGA-3′ (in this case, the N is a G), indicating cleavage between the N and the G of the recognition sequence (FIG. 2, forward panel). Digestion of the extension reaction product from primer M13 Q2-2 with Hpy188I endonuclease produced a band which also co-migrated with the unspecified nucleotide of the Hpy188I recognition sequence 5′-TCNGA-3′ (in this case, the N is the C on the opposite strand of DNA from the G in the M13 Q1-Q2 reaction), indicating cleavage between the N and the G of the recognition sequence on this strand of DNA as well (FIG. 2, panel B). These results indicate Hpy188I cleaves DNA between the N and G in its recognition sequence on both DNA strands, 5′-TCN/GA-3′, to produce a one base 3′ extension.

EXAMPLE III Cloning the Hpy188I Endonuclease and Methylase

1. DNA purification: To prepare the genomic DNA of Helicobacter pylori J188, 1 gram of cell paste was resuspended in 10 ml of 25% sucrose, 0.05 M Tris-HCl pH 8.0, to which was added 5 ml of 0.25 M EDTA, pH 8.0. Then 3 ml of lysozyme solution (10 mg/ml lysozyme in 0.25 M Tris-HCl, pH 8.0) was added and the cell suspension was incubated at 4° C. for 16 hours. 12 ml of Lytic mix (1% Triton-X100, 0.05 M Tris, 62 mM EDTA, pH 8.0) and 2.5 ml of 10% SDS was then added and the solution was incubated at 37° C. for 5 minutes. The solution was extracted with one volume of equilibrated phenol:chloroform:isoamyl alcohol (50:48:2, v/v/v) and the aqueous phase was recovered and extracted with one volume of chloroform:isoamyl alcohol (24:1, v/v) two times. The aqueous solution was then dialysed against four changes of 2 L of 10 mM Tris, 1 mM EDTA, pH 8.0. The dialysed DNA solution was digested with RNase (100 μg/ml) at 37° C. for 1 hour. The DNA was precipitated by the addition of {fraction (1/10)}th volume 5 M NaCl and 0.55 volumes of 2-propanol and spooled on a glass rod. The DNA was briefly rinsed in 70% ethanol, air dried and dissolved in 3 ml TE (10 mM Tris, 1 mM EDTA, pH 8.0) to a concentration of approximately 300 mg/ml and stored at 4° C.

2. Contruction of libraries of genomic Helicobacter pylori J188 DNA in a selectable vector:

Helicobacter pylori J188 genomic DNA was partially digested with either of two frequent cutting enzymes, Sau3AI or AciI. The partial digestion was carried out by serial dilution of the Sau3AI or the AciI restriction endonuclease from 0.5 units/ag DNA to 0.016 units/μg in the manufacturer's reaction buffer and digesting at 37° C. for 1 hour. The reactions were subsequently terminated by phenol:chloroform extraction. Reactions which produced an average size range of fragments from 2 to 6 kb were used for library construction. 3 μg of this partially digested Hpy188I genomic DNA was ligated to 1 μg of the vector pUC19 (previously cleaved by BamHI (Sau3AI) or AccI (AciI) and dephosphorylated with calf intestinal alkaline phosphatase) in a final volume of 50 μl in 1×NEB ligase buffer with 1000 units (NEB) of T4 DNA ligase. The ligation reactions were incubated at 16° C. for 16 hours. 10 ul of each ligation reaction mixture was then transformed by electroporation into E. coli ER2683 cells and grown out in 10 ml L-Broth for 1 hour. 10 μl was then plated onto L-Broth agar plates supplemented with 100 μg/ml ampicillin to count the number transformants and the plates were incubated at 37° C. overnight. The remaining outgrowth was grown overnight in 250 ml L-Broth supplemented with 100 μg/ml ampicillin with shaking at 37° C. A total of 1×10⁶individual transformants were obtained for the Sau3Ai library, and 6×10⁵transformants for the AciI library. The cells of the 250 ml liquid culture were harvested by centrifugation at 5 K rpm for 5 minutes. The plasmids from these cells were purified by a standard alkaline lysis procedure, followed by four rounds of desalting in an Amicon Centricon-50 microconcentration device, washing with TE buffer each round, and then the plasmids were precipitated by PEG precipitation (combined 672 μl centricon purified plasmid, 128 μl 5 M NaCl and 800 μl 13% PEG-8000, incubated at 4° C. for 30 min, microfuged at 4° C. at maximum speed for 10 minutes, washed 2× with 70% cold ethanol) and resuspended in TE buffer at a concentration of 250 μg/ml .

3. Hpy188I methylase selection: 1 μg of the plasmid library was digested for 4 hours at 37° C. in 100 μl 1× NEB#4 buffer with 24, 12, 6 and 3 units of the Hpy188I prepared as above from H.pylori J188 cells. 10 μl of the Hpy188I digestion reaction was then transformed into 100 μl E. coli ER2688 competent cells and plated on L-broth plates containing 100 ug/ml ampicillin and the plates incubated at 37° C. overnight. A total of 24 transformants were obtained from the AciI library digested with 24 units from Hpy188I and more than 60 from the Sau3AI library. 60 of the Sau3AI library clones and 10 of the AciI library clones were analyzed as follows: Plasmid from each colony was isolated by miniprep procedures and digested with Hpy188I endonuclease.

Analysis of plasmid clones: Individual transformants were inoculated into 10 ml cultures of L-broth containing 100 μg/ml ampicillin and the plasmids that they carried were prepared by Qiagen QIAprep® Spin Miniprep columns according to the manufacturers instructions. Plasmids were assayed for the presence of the Hpy188I methylase by digestion with Hpy188I endonuclease.

3 of 60 clones analyzed from the Sau3AI library were found to be fully protected from Hpy188I digestion. Further restriction analysis showed these clones contained common Sau3AI and HindIII restriction fragments. All three clones were tested for and found to express Hpy188I restriction activity when grown in L-Broth containing 100 μg/ml ampicillin. 2 of 10 clones analyzed from the AciI library were found to be fully protected from Hpy188I digestion. Both clones were tested for and found to express Hpy188I restriction activity when grown in L-Broth containing 100 μg/ml ampicillin. One such clone was designated pHpy188IA1 (strain NEB#1175) and may be used to produce Hpy188I endonuclease by propagation to mid-log phase in a fermenter containing L-broth medium with ampicillin (100 μg/ml). The cells are harvested by centrifugation and may be stored at −20° C. or used immediately.

4. Purification of the Hpy188I restriction endonuclease from NEB #1175 can be accomplished by a combination of standard protein purification techniques, such as affinity-chromatography or ion-exchange chromatography, as outlined above. The Hpy188I restriction endonuclease obtained from this purification is substantially pure and free of non-specific endonuclease and exonuclease contamination.

EXAMPLE IV Sequencing the Hpy188I Endonuclease and Methylase

1. DNA Sequencing: DNA sequencing, performed on double-stranded templates on an ABI automated sequencer, was based on reading of both strands and compiled with the Staden alignment programs (Staden, R. Nuclei Acids Res. 10:4731-4751 (1982).). Computer analyses of DNA and protein sequences were performed with the Genetics Computer Group programs (Deverenx, et al., Nucleic Acids Res. 12:387-395 (1984)) and database similarity searches were performed via electronic mail to the National Center for Biotechnology Information using the BLASTX algorithm (Altschul, et al., J. Mol. Biol 215:403-410 (1990) and Gish, et al., Nature Genet. 3:266 (1993)). An open reading frame (ORF) of 1299 bp which contained motifs characteristic of DNA methyl-transferases was identified and designated Hpy188IM, the Hpy188I methyl-transferase.

2. Amino terminal Hpy188I protein sequence: The approximately 19 kD protein band obtained in Example I above was subjected to amino terminal protein sequencing on an Applied BioSystems Division, Perkin-Elmer Corporation (Foster City, Calif.) Model 407A gas phase protein sequencer (Brooks, et al., Nucleic Acids Research, 17:979-997 (1989)). The sequence of the first 28 residues obtained was the following: (M)XKRKXDIILKSVDDLKDXIDXKDFXYK (SEQ ID NO:6). This amino acid sequence data from the amino terminus of the Hpy188I endonuclease protein matched the deduced amino acid sequence of the 513bp ORF identified in the DNA sequence of clone Hpy188IA1, which ORF is thus designated Hpy188IR, the Hpy188I endonuclease gene.

A sample of an E. coli containing pHpy188IA1 (NEB#1175) has been deposited under the terms and conditions of the Budapest Treaty with the American Type Culture Collection on , Sep. 9, 1999, and received ATCC Pat. Accession No. PTA-631.

7 1 1822 DNA Helicobacter pylori CDS (52)..(1350) 1 tgatataatg gatttaggaa acgccaataa aattaaaaag gttcaaaaat a gtg tta 57 Val Leu 1 tct ctc cct ttg ata gaa aaa cgc cct ttt tta aat cac gaa cgc atc 105 Ser Leu Pro Leu Ile Glu Lys Arg Pro Phe Leu Asn His Glu Arg Ile 5 10 15 aaa tta cat agt ttt tcg caa gtt aaa gcg tat ttt gac aca ctc aat 153 Lys Leu His Ser Phe Ser Gln Val Lys Ala Tyr Phe Asp Thr Leu Asn 20 25 30 ttt gac aca agt cat ttt gtt aat tct aat gat att tgc acc cca tta 201 Phe Asp Thr Ser His Phe Val Asn Ser Asn Asp Ile Cys Thr Pro Leu 35 40 45 50 gat tgt gtg aaa gaa atg ata gac act atc cca agc gat ttt ttt aaa 249 Asp Cys Val Lys Glu Met Ile Asp Thr Ile Pro Ser Asp Phe Phe Lys 55 60 65 caa gaa cat tta aaa att tta gat tgt tgt tgt ggg aat ggg aat ttt 297 Gln Glu His Leu Lys Ile Leu Asp Cys Cys Cys Gly Asn Gly Asn Phe 70 75 80 ttt gct tat tta gag act aag act tct cta aac aat ctg tat ttt aat 345 Phe Ala Tyr Leu Glu Thr Lys Thr Ser Leu Asn Asn Leu Tyr Phe Asn 85 90 95 gag att aac cct aaa cgc att gag cat gtt aaa aaa tat ttt ggg agc 393 Glu Ile Asn Pro Lys Arg Ile Glu His Val Lys Lys Tyr Phe Gly Ser 100 105 110 aat atc cat tta agc tgt aag gat ttt tta aaa ttt gat agg gct acg 441 Asn Ile His Leu Ser Cys Lys Asp Phe Leu Lys Phe Asp Arg Ala Thr 115 120 125 130 ctt tat gac tta atc gtg gct aac cca cct ttt gct aaa ttt aat gcg 489 Leu Tyr Asp Leu Ile Val Ala Asn Pro Pro Phe Ala Lys Phe Asn Ala 135 140 145 cta ggt cgc act tct aaa aat cat aat ctg gca aga gac ttt att aaa 537 Leu Gly Arg Thr Ser Lys Asn His Asn Leu Ala Arg Asp Phe Ile Lys 150 155 160 aaa gcc tta gag ctt aca aaa aat ggg ggt tat att cta ttc att gtg 585 Lys Ala Leu Glu Leu Thr Lys Asn Gly Gly Tyr Ile Leu Phe Ile Val 165 170 175 cct aat cat tgg atg agt ttt tca gat agg aat gtt tta ccc aac tta 633 Pro Asn His Trp Met Ser Phe Ser Asp Arg Asn Val Leu Pro Asn Leu 180 185 190 ctc tca caa tat caa ttt atc cat ctt aat att ggc gga gct aaa aaa 681 Leu Ser Gln Tyr Gln Phe Ile His Leu Asn Ile Gly Gly Ala Lys Lys 195 200 205 210 tac ttt aaa aaa gtt ggc tca tct ttc act tgg ttt tta ttg caa aaa 729 Tyr Phe Lys Lys Val Gly Ser Ser Phe Thr Trp Phe Leu Leu Gln Lys 215 220 225 gtc cct aat caa aaa agt ttt agc gta gaa aat cat tat gtt tta aaa 777 Val Pro Asn Gln Lys Ser Phe Ser Val Glu Asn His Tyr Val Leu Lys 230 235 240 gac aga caa aga gtt tcg ctt aga act cat tta aat ttc att ccc ttg 825 Asp Arg Gln Arg Val Ser Leu Arg Thr His Leu Asn Phe Ile Pro Leu 245 250 255 tat tta aac gaa ttg gtt tgt agc att tta gat aaa acg atc aat aat 873 Tyr Leu Asn Glu Leu Val Cys Ser Ile Leu Asp Lys Thr Ile Asn Asn 260 265 270 act cat tta cct acc tat aaa ata gaa acg aca agc ttt cta cac agg 921 Thr His Leu Pro Thr Tyr Lys Ile Glu Thr Thr Ser Phe Leu His Arg 275 280 285 290 aca acc aag aaa gaa ttt tta tcg ccc att caa aat aag gac tac cct 969 Thr Thr Lys Lys Glu Phe Leu Ser Pro Ile Gln Asn Lys Asp Tyr Pro 295 300 305 tat aag att atc cat acc cct agt caa gtc gta tat agt aaa atc ccc 1017 Tyr Lys Ile Ile His Thr Pro Ser Gln Val Val Tyr Ser Lys Ile Pro 310 315 320 cac aaa tac caa gaa ggc tat aaa gtc ttt tta tct ttg act aat caa 1065 His Lys Tyr Gln Glu Gly Tyr Lys Val Phe Leu Ser Leu Thr Asn Gln 325 330 335 tac agc aca ttt att gat aat tgc ggc atg aca caa agc att gcg ttt 1113 Tyr Ser Thr Phe Ile Asp Asn Cys Gly Met Thr Gln Ser Ile Ala Phe 340 345 350 gtg cgt tgc aaa aac tac gaa gag gcc tta aaa att aaa acc gaa tta 1161 Val Arg Cys Lys Asn Tyr Glu Glu Ala Leu Lys Ile Lys Thr Glu Leu 355 360 365 370 gat aat gag att tat tta ttt ctt aat aat ctc act cgt tat gga aat 1209 Asp Asn Glu Ile Tyr Leu Phe Leu Asn Asn Leu Thr Arg Tyr Gly Asn 375 380 385 ttt aat aac att aga gtg tta cag cat tta cct tta tta gaa agt att 1257 Phe Asn Asn Ile Arg Val Leu Gln His Leu Pro Leu Leu Glu Ser Ile 390 395 400 gtt cta aac aag caa gaa tta gaa ttt atc caa aaa ttt aat gag gcg 1305 Val Leu Asn Lys Gln Glu Leu Glu Phe Ile Gln Lys Phe Asn Glu Ala 405 410 415 tat tat ggc aaa aag aaa gag cga tat aat ttt aaa gag tgt tga 1350 Tyr Tyr Gly Lys Lys Lys Glu Arg Tyr Asn Phe Lys Glu Cys 420 425 430 tgatttaaaa gatgaaattg attacaagga ctttgaatac aaagagtatt ttaatttatt 1410 atgcgaatta gtccctaata atagtttgga aaaattagaa atcaacgcca ttgatgaaaa 1470 gaatatgaaa aacgaaggac ttgtatatgt gtttgttatt caaggtaaaa tttttaaaat 1530 cggtcatagt attacgccca tcacaaagcg agtgcaatct tataattgcg gcaaagtaga 1590 atatcgtaaa aatggcactt gctccacaac aaattatttt gtattgcaat cgctcttaaa 1650 gattaataaa atcgtacaag tgtatgcatt ttttccagaa caacctacct ataccctatt 1710 tggtaaaact taccaagata gtttttcaac ttctaaaagg gctgagaatg tgattttaga 1770 aaattttatt aaaaatcata ataaaaaacc tatcggatgc acacagactt aa 1822 2 432 PRT Helicobacter pylori 2 Val Leu Ser Leu Pro Leu Ile Glu Lys Arg Pro Phe Leu Asn His Glu 1 5 10 15 Arg Ile Lys Leu His Ser Phe Ser Gln Val Lys Ala Tyr Phe Asp Thr 20 25 30 Leu Asn Phe Asp Thr Ser His Phe Val Asn Ser Asn Asp Ile Cys Thr 35 40 45 Pro Leu Asp Cys Val Lys Glu Met Ile Asp Thr Ile Pro Ser Asp Phe 50 55 60 Phe Lys Gln Glu His Leu Lys Ile Leu Asp Cys Cys Cys Gly Asn Gly 65 70 75 80 Asn Phe Phe Ala Tyr Leu Glu Thr Lys Thr Ser Leu Asn Asn Leu Tyr 85 90 95 Phe Asn Glu Ile Asn Pro Lys Arg Ile Glu His Val Lys Lys Tyr Phe 100 105 110 Gly Ser Asn Ile His Leu Ser Cys Lys Asp Phe Leu Lys Phe Asp Arg 115 120 125 Ala Thr Leu Tyr Asp Leu Ile Val Ala Asn Pro Pro Phe Ala Lys Phe 130 135 140 Asn Ala Leu Gly Arg Thr Ser Lys Asn His Asn Leu Ala Arg Asp Phe 145 150 155 160 Ile Lys Lys Ala Leu Glu Leu Thr Lys Asn Gly Gly Tyr Ile Leu Phe 165 170 175 Ile Val Pro Asn His Trp Met Ser Phe Ser Asp Arg Asn Val Leu Pro 180 185 190 Asn Leu Leu Ser Gln Tyr Gln Phe Ile His Leu Asn Ile Gly Gly Ala 195 200 205 Lys Lys Tyr Phe Lys Lys Val Gly Ser Ser Phe Thr Trp Phe Leu Leu 210 215 220 Gln Lys Val Pro Asn Gln Lys Ser Phe Ser Val Glu Asn His Tyr Val 225 230 235 240 Leu Lys Asp Arg Gln Arg Val Ser Leu Arg Thr His Leu Asn Phe Ile 245 250 255 Pro Leu Tyr Leu Asn Glu Leu Val Cys Ser Ile Leu Asp Lys Thr Ile 260 265 270 Asn Asn Thr His Leu Pro Thr Tyr Lys Ile Glu Thr Thr Ser Phe Leu 275 280 285 His Arg Thr Thr Lys Lys Glu Phe Leu Ser Pro Ile Gln Asn Lys Asp 290 295 300 Tyr Pro Tyr Lys Ile Ile His Thr Pro Ser Gln Val Val Tyr Ser Lys 305 310 315 320 Ile Pro His Lys Tyr Gln Glu Gly Tyr Lys Val Phe Leu Ser Leu Thr 325 330 335 Asn Gln Tyr Ser Thr Phe Ile Asp Asn Cys Gly Met Thr Gln Ser Ile 340 345 350 Ala Phe Val Arg Cys Lys Asn Tyr Glu Glu Ala Leu Lys Ile Lys Thr 355 360 365 Glu Leu Asp Asn Glu Ile Tyr Leu Phe Leu Asn Asn Leu Thr Arg Tyr 370 375 380 Gly Asn Phe Asn Asn Ile Arg Val Leu Gln His Leu Pro Leu Leu Glu 385 390 395 400 Ser Ile Val Leu Asn Lys Gln Glu Leu Glu Phe Ile Gln Lys Phe Asn 405 410 415 Glu Ala Tyr Tyr Gly Lys Lys Lys Glu Arg Tyr Asn Phe Lys Glu Cys 420 425 430 3 1822 DNA Helicobacter pylori CDS (1310)..(1819) 3 tgatataatg gatttaggaa acgccaataa aattaaaaag gttcaaaaat agtgttatct 60 ctccctttga tagaaaaacg ccctttttta aatcacgaac gcatcaaatt acatagtttt 120 tcgcaagtta aagcgtattt tgacacactc aattttgaca caagtcattt tgttaattct 180 aatgatattt gcaccccatt agattgtgtg aaagaaatga tagacactat cccaagcgat 240 ttttttaaac aagaacattt aaaaatttta gattgttgtt gtgggaatgg gaattttttt 300 gcttatttag agactaagac ttctctaaac aatctgtatt ttaatgagat taaccctaaa 360 cgcattgagc atgttaaaaa atattttggg agcaatatcc atttaagctg taaggatttt 420 ttaaaatttg atagggctac gctttatgac ttaatcgtgg ctaacccacc ttttgctaaa 480 tttaatgcgc taggtcgcac ttctaaaaat cataatctgg caagagactt tattaaaaaa 540 gccttagagc ttacaaaaaa tgggggttat attctattca ttgtgcctaa tcattggatg 600 agtttttcag ataggaatgt tttacccaac ttactctcac aatatcaatt tatccatctt 660 aatattggcg gagctaaaaa atactttaaa aaagttggct catctttcac ttggttttta 720 ttgcaaaaag tccctaatca aaaaagtttt agcgtagaaa atcattatgt tttaaaagac 780 agacaaagag tttcgcttag aactcattta aatttcattc ccttgtattt aaacgaattg 840 gtttgtagca ttttagataa aacgatcaat aatactcatt tacctaccta taaaatagaa 900 acgacaagct ttctacacag gacaaccaag aaagaatttt tatcgcccat tcaaaataag 960 gactaccctt ataagattat ccatacccct agtcaagtcg tatatagtaa aatcccccac 1020 aaataccaag aaggctataa agtcttttta tctttgacta atcaatacag cacatttatt 1080 gataattgcg gcatgacaca aagcattgcg tttgtgcgtt gcaaaaacta cgaagaggcc 1140 ttaaaaatta aaaccgaatt agataatgag atttatttat ttcttaataa tctcactcgt 1200 tatggaaatt ttaataacat tagagtgtta cagcatttac ctttattaga aagtattgtt 1260 ctaaacaagc aagaattaga atttatccaa aaatttaatg aggcgtatt atg gca aaa 1318 Met Ala Lys 1 aga aag agc gat ata att tta aag agt gtt gat gat tta aaa gat gaa 1366 Arg Lys Ser Asp Ile Ile Leu Lys Ser Val Asp Asp Leu Lys Asp Glu 5 10 15 att gat tac aag gac ttt gaa tac aaa gag tat ttt aat tta tta tgc 1414 Ile Asp Tyr Lys Asp Phe Glu Tyr Lys Glu Tyr Phe Asn Leu Leu Cys 20 25 30 35 gaa tta gtc cct aat aat agt ttg gaa aaa tta gaa atc aac gcc att 1462 Glu Leu Val Pro Asn Asn Ser Leu Glu Lys Leu Glu Ile Asn Ala Ile 40 45 50 gat gaa aag aat atg aaa aac gaa gga ctt gta tat gtg ttt gtt att 1510 Asp Glu Lys Asn Met Lys Asn Glu Gly Leu Val Tyr Val Phe Val Ile 55 60 65 caa ggt aaa att ttt aaa atc ggt cat agt att acg ccc atc aca aag 1558 Gln Gly Lys Ile Phe Lys Ile Gly His Ser Ile Thr Pro Ile Thr Lys 70 75 80 cga gtg caa tct tat aat tgc ggc aaa gta gaa tat cgt aaa aat ggc 1606 Arg Val Gln Ser Tyr Asn Cys Gly Lys Val Glu Tyr Arg Lys Asn Gly 85 90 95 act tgc tcc aca aca aat tat ttt gta ttg caa tcg ctc tta aag att 1654 Thr Cys Ser Thr Thr Asn Tyr Phe Val Leu Gln Ser Leu Leu Lys Ile 100 105 110 115 aat aaa atc gta caa gtg tat gca ttt ttt cca gaa caa cct acc tat 1702 Asn Lys Ile Val Gln Val Tyr Ala Phe Phe Pro Glu Gln Pro Thr Tyr 120 125 130 acc cta ttt ggt aaa act tac caa gat agt ttt tca act tct aaa agg 1750 Thr Leu Phe Gly Lys Thr Tyr Gln Asp Ser Phe Ser Thr Ser Lys Arg 135 140 145 gct gag aat gtg att tta gaa aat ttt att aaa aat cat aat aaa aaa 1798 Ala Glu Asn Val Ile Leu Glu Asn Phe Ile Lys Asn His Asn Lys Lys 150 155 160 cct atc gga tgc aca cag act taa 1822 Pro Ile Gly Cys Thr Gln Thr 165 170 4 170 PRT Helicobacter pylori 4 Met Ala Lys Arg Lys Ser Asp Ile Ile Leu Lys Ser Val Asp Asp Leu 1 5 10 15 Lys Asp Glu Ile Asp Tyr Lys Asp Phe Glu Tyr Lys Glu Tyr Phe Asn 20 25 30 Leu Leu Cys Glu Leu Val Pro Asn Asn Ser Leu Glu Lys Leu Glu Ile 35 40 45 Asn Ala Ile Asp Glu Lys Asn Met Lys Asn Glu Gly Leu Val Tyr Val 50 55 60 Phe Val Ile Gln Gly Lys Ile Phe Lys Ile Gly His Ser Ile Thr Pro 65 70 75 80 Ile Thr Lys Arg Val Gln Ser Tyr Asn Cys Gly Lys Val Glu Tyr Arg 85 90 95 Lys Asn Gly Thr Cys Ser Thr Thr Asn Tyr Phe Val Leu Gln Ser Leu 100 105 110 Leu Lys Ile Asn Lys Ile Val Gln Val Tyr Ala Phe Phe Pro Glu Gln 115 120 125 Pro Thr Tyr Thr Leu Phe Gly Lys Thr Tyr Gln Asp Ser Phe Ser Thr 130 135 140 Ser Lys Arg Ala Glu Asn Val Ile Leu Glu Asn Phe Ile Lys Asn His 145 150 155 160 Asn Lys Lys Pro Ile Gly Cys Thr Gln Thr 165 170 5 20 DNA Helicobacter pylori 5 ggtcgctgag gcttgcaggg 20 6 28 PRT Helicobacter pylori At positions 2, 6, 19, 22 and 26 “Xaa” = any amino acid 6 Met Xaa Lys Arg Lys Xaa Asp Ile Ile Leu Lys Ser Val Asp Asp Leu 1 5 10 15 Lys Asp Xaa Ile Asp Xaa Lys Asp Phe Xaa Tyr Lys 20 25 7 20 DNA Helicobacter pylori 7 cgtttaatgg aaacttcctc 20

Claims

What is claimed is:

1. Isolated DNA coding for the Hpy188I restriction endonuclease, wherein the isolated DNA is obtainable from Helicobacter pylori J188.

2. A recombinant DNA vector comprising a vector into which a DNA segment coding for the Hpy188I restriction endonuclease has been inserted.

3. Isolated DNA coding for the Hpy188I restriction endonuclease and methylase, wherein the isolated DNA is obtainable from ATCC No. PTA-631.

4. A cloning vector which comprises the isolated DNA of claim 3.

5. A host cell transformed by the vector of claim 2 or 4.

6. A method of producing an Hpy188I restriction endonuclease comprising culturing a host cell transformed with the vector of claim 2 or 4 under conditions suitable for expression of said endonuclease.

7. A substantially pure Type II restriction endonuclease obtainable from Helicobacter pylori J188 recognizing the following base sequence in double-stranded deoxyribonucleic acid molecules:

5′-TCN↓GA-3′

3′-AG↑NCT-5′

and having a cleavage position defined by the arrows.

8. A method for obtaining the Type II restriction endonuclease of claim 7, comprising cultivating a sample of Helicobacter pylori under conditions favoring the production of said endonuclease and separating said endonuclease therefrom.

9. The Type II restriction endonuclease of claim 7, wherein the restriction endonuclease is purified from ATCC No. PTA-2878.

10. A Type II restriction endonuclease with 90% or greater amino acid sequence identity to the Type II restriction endonuclease of claim 7, obtainable from Helicobacter species.